mizoribine has been researched along with Proteinuria in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.50) | 18.7374 |
| 1990's | 7 (17.50) | 18.2507 |
| 2000's | 12 (30.00) | 29.6817 |
| 2010's | 17 (42.50) | 24.3611 |
| 2020's | 3 (7.50) | 2.80 |
| Authors | Studies |
|---|---|
| Aoto, Y; Fujimura, J; Horinouchi, T; Ichikawa, Y; Iijima, K; Ishimori, S; Kaito, H; Kamiyoshi, N; Kitakado, H; Kondo, A; Nagai, S; Nakanishi, K; Ninchoji, T; Nozu, K; Sakakibara, N; Shima, Y; Tanaka, R; Tanaka, Y; Ueda, C; Yoshikawa, N | 1 |
| Enya, T; Miyazaki, K; Miyazawa, T; Okada, M; Sugimoto, K; Takemura, T | 1 |
| Craig, JC; Molony, DA; Natale, P; Palmer, SC; Ruospo, M; Saglimbene, VM; Samuels, JA; Schena, FP; Strippoli, GF; Vecchio, M | 1 |
| Hataya, H; Honda, M; Iijima, K; Ishikura, K; Kaku, Y; Matsuyama, T; Nakanishi, K; Nozu, K; Sako, M; Shima, Y; Tanaka, R; Yoshikawa, N | 1 |
| Mii, A; Shimizu, A; Takada, D; Tsuruoka, S | 1 |
| Liu, J; Xing, CY; Zhang, M | 1 |
| Matsumoto, Y; Moriki, T; Nojima, Y; Shimada, Y | 1 |
| Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y | 1 |
| Hanada, K; Ito, T; Mochizuki, K; Oka, T; Tanabe, K | 1 |
| Fukui, M; Kaneko, T; Mii, A; Nagahama, K; Shimizu, A; Tsuruoka, S | 1 |
| Arai, M; Hirama, A; Ikeda, M; Kaneko, T; Morita, M; Shimizu, A; Tsuruoka, S; Watanabe, Y | 1 |
| Hirakata, H; Hirakawa, M; Katafuchi, R; Kitazono, T; Masutani, K; Mitsuiki, K; Tsuchimoto, A; Tsuruya, K; Yamada, T | 1 |
| Mima, A | 1 |
| Abe, H; Furuno, Y; Kabashima, N; Matsumoto, M; Miyamoto, T; Miyazaki, M; Nakamata, J; Okazaki, M; Otsuji, Y; Serino, R; Shibata, T; Takeuchi, M; Tamura, M; Tokunaga, M | 1 |
| Ando, T; Hattori, S; Honda, M; Ikeda, M; Sasaki, S; Tanaka, Y; Yoshikawa, N | 1 |
| Fujita, T; Fuke, Y; Ito, K; Matsumoto, K; Satomura, A; Shimizu, C | 1 |
| Hashimoto, K; Hosoya, M; Kawasaki, Y; Suyama, K | 1 |
| Hirayama, K; Kobayashi, M | 1 |
| Chen, P; Chen, X; Huang, S; Li, Y; Lie, C; Liu, S; Miao, L; Wang, L; Wu, X; Xie, Y; Zhang, A | 1 |
| Fujita, S; Iharada, A; Kaneko, K; Miyazaki, K; Okada, M; Sakata, N; Sugimoto, K; Takemura, T; Tsuji, S; Yanagida, H | 1 |
| Hara, T; Hiromasa, T; Kagawa, H; Makino, H; Sada, KE; Takaki, A; Yamanaka, R | 1 |
| Ikeda, M; Kuwajima, H; Okada, M; Sugimoto, K; Takemura, T; Yagi, K; Yanagida, H | 1 |
| Arakawa, M; Harada, T; Hishida, A; Ishida, M; Ishikawa, I; Kashihara, N; Kobayashi, Y; Koike, T; Koyama, A; Maeda, K; Makino, H; Mitarai, T; Muso, E; Nagasawa, T; Nagase, M; Nojima, Y; Osawa, G; Saito, T; Sakai, O; Sato, H; Sato, M; Shibasaki, T; Shiiki, H; Sugisaki, T; Tomino, Y; Tomita, K; Yamabe, H; Yorioka, N | 1 |
| Imanaka, H; Kawano, Y; Maeno, N; Ohkawa, T; Takei, S; Yoshidome, K | 1 |
| Chihara, Y; Fujimori, T; Iidaka, K; Inada, H; Ishimitsu, T; Matsuoka, H; Ogihara, T; Ono, H; Ono, Y; Rakugi, H; Ueda, Y | 1 |
| Kumasaka, R; Nakamura, M; Nakamura, N; Shimada, M; Tsunoda, S; Yamabe, H | 1 |
| Harada, T; Horita, Y; Kohno, S; Miyazaki, M; Nishioka, Y; Suyama, N; Tadokoro, M; Taura, K | 1 |
| Ajiro, J; Gejyo, F; Hasegawa, H; Hirose, S; Ito, S; Kuroda, T; Murakami, S; Nakano, M; Nakatsue, T; Sakatsume, M; Sato, H; Tanabe, N; Wada, Y | 1 |
| Bessho, F; Hagiwara, E; Kawakami, H; Khoshnoodi, J; Kurayama, R; Nakajo, A; Sekine, Y; Swiatecka-Urban, A; Takahashi, S; Takenaka, H; Tryggvason, K; Watanabe, T; Yan, K | 1 |
| Ikezumi, Y; Karasawa, T; Kawachi, H; Nikolic-Paterson, DJ; Suzuki, T; Uchiyama, M | 1 |
| Hataya, H; Honda, M; Iijima, K; Ishikura, K; Nakanishi, K; Yoshikawa, N | 1 |
| Kobayashi, Y; Masaki, Y; Shigematsu, H | 1 |
| Igarashi, Y; Inoue, CN; Kondo, Y; Moro, Y | 1 |
| Ishikawa, N; Nakada, T; Ota, K; Tanabe, K; Tokumoto, N; Toma, H; Yagisawa, T; Yaguchi, H | 1 |
| Akiyama, T; Kanda, H; Kurita, T; Nagano, T; Uemura, T | 1 |
| Gomi, H; Ishimoto, F; Matsuda, H; Sakai, O; Shibasaki, T; Usui, M | 1 |
| Ishigatsubo, Y; Kitamura, H; Okubo, T; Soga, T | 1 |
| Abe, M; Shimizu, M; Shou, I; Tomino, Y; Tsuge, T | 1 |
| Kaneko, K; Nagaoka, R; Ohtomo, Y; Yamashiro, Y | 1 |
| Ebihara, I; Koide, H; Nakamura, T; Sekizuka, K; Shimada, N; Suzuki, S; Ushiyama, C | 1 |
2 review(s) available for mizoribine and Proteinuria
| Article | Year |
|---|---|
Immunosuppressive agents for treating IgA nephropathy.
Topics: Adult; Calcineurin Inhibitors; Cause of Death; Child; Confidence Intervals; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Leflunomide; Mycophenolic Acid; Proteinuria; Randomized Controlled Trials as Topic; Remission Induction; Ribonucleosides; Risk; Steroids | 2020 |
[Minimal change nephrotic syndrome].
Topics: Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Methylprednisolone; Nephrosis, Lipoid; Prednisolone; Proteinuria; Pulse Therapy, Drug; Ribonucleosides | 2010 |
10 trial(s) available for mizoribine and Proteinuria
| Article | Year |
|---|---|
Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
Topics: Adolescent; Biopsy; Child; Dipyridamole; Drug Therapy, Combination; Female; Glomerular Mesangium; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Prednisolone; Prospective Studies; Proteinuria; Ribonucleosides; Severity of Illness Index; Treatment Outcome; Warfarin | 2018 |
Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
Topics: Adult; Aged; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Prednisone; Proteinuria; Remission Induction; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2013 |
Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.
Topics: Adult; Blood Pressure; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Male; Methylprednisolone; Middle Aged; Prospective Studies; Proteinuria; Ribonucleosides | 2016 |
Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Age of Onset; Child; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Proteinuria; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Time Factors; Treatment Outcome | 2010 |
Efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: a multicenter, randomized, controlled study.
Topics: Adult; Angiotensin Receptor Antagonists; Blood Pressure; China; Creatinine; Drug Synergism; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Longitudinal Studies; Losartan; Male; Prospective Studies; Proteinuria; Ribonucleosides; Treatment Outcome; Uric Acid | 2011 |
Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Topics: Adolescent; Adult; Age of Onset; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Child; Child, Preschool; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney; Male; Prednisone; Proteinuria; Ribonucleosides; Treatment Outcome; Vasodilator Agents | 2003 |
A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
Topics: Adult; Drug Resistance; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Patient Dropouts; Product Surveillance, Postmarketing; Proteinuria; Remission Induction; Ribonucleosides; Steroids | 2004 |
Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Blood Sedimentation; Child; Complement C3; Complement C4; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Proteinuria; Ribonucleosides; Time Factors; Treatment Outcome | 2004 |
Mizoribine therapy for patients with lupus nephritis: the association between peak mizoribine concentration and clinical efficacy.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Lupus Nephritis; Middle Aged; Proteinuria; Ribonucleosides; Treatment Outcome | 2007 |
Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.
Topics: Biopsy; Child; Dipyridamole; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunoglobulin A; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Glomerulus; Male; Pilot Projects; Platelet Aggregation Inhibitors; Prednisolone; Prospective Studies; Proteinuria; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2008 |
28 other study(ies) available for mizoribine and Proteinuria
| Article | Year |
|---|---|
Long-term outcome of combination therapy with corticosteroids, mizoribine and RAS inhibitors as initial therapy for severe childhood IgA vasculitis with nephritis.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Child; Humans; IgA Vasculitis; Nephritis; Proteinuria; Retrospective Studies | 2023 |
Membranoproliferative glomerulonephritis related to a streptococcal infection in a girl with IgA deficiency: a case report.
Topics: Angiotensin-Converting Enzyme Inhibitors; Child, Preschool; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Humans; IgA Deficiency; Kidney Glomerulus; Prednisolone; Proteinuria; Ribonucleosides; Streptococcal Infections | 2020 |
Proliferative glomerulonephritis with unusual microlamellar organized deposits related to monoclonal immunoglobulin G3 (IgG3) kappa.
Topics: Aged; Female; Glomerulonephritis; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Immunosuppressive Agents; Kidney Glomerulus; Prednisolone; Proteinuria; Ribonucleosides; Treatment Outcome | 2018 |
Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
Topics: Adolescent; Adult; Asian People; China; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Middle Aged; Prednisolone; Proteinuria; Remission Induction; Ribonucleosides; Treatment Outcome | 2013 |
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome | 2015 |
Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine.
Topics: Aged; Anti-Inflammatory Agents; Creatinine; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Prednisolone; Proteinuria; Retrospective Studies; Ribonucleosides | 2015 |
IgA nephropathy and psoriatic arthritis that improved with steroid pulse therapy and mizoribine in combination with treatment for chronic tonsillitis and epipharyngitis.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Psoriatic; Chronic Disease; Combined Modality Therapy; Glomerulonephritis, IGA; Humans; Male; Pharyngitis; Proteinuria; Pulse Therapy, Drug; Ribonucleosides; Steroids; Tonsillitis; Treatment Outcome | 2015 |
Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
Topics: Adult; Anti-Inflammatory Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Hematuria; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Prednisolone; Proteinuria; Ribonucleosides; Tonsillectomy; Young Adult | 2015 |
Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Therapy, Combination; Hematuria; Humans; IgA Vasculitis; Immunoglobulin A; Immunosuppressive Agents; Male; Prednisolone; Proteinuria; Retrospective Studies; Ribonucleosides | 2017 |
Mizoribine for relapsed proteinuria in an adult IgA nephropathy patient.
Topics: Dose-Response Relationship, Drug; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Middle Aged; Proteinuria; Recurrence; Ribonucleosides | 2008 |
Anti-proteinuric effect of mizoribine monotherapy in three patients with membranous nephropathy.
Topics: Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Middle Aged; Proteinuria; Ribonucleosides | 2010 |
Methylprednisolone pulse plus mizoribine in children with Henoch-Schoenlein purpura nephritis.
Topics: Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; IgA Vasculitis; Immunosuppressive Agents; Male; Methylprednisolone; Prognosis; Prospective Studies; Proteinuria; Pulse Therapy, Drug; Ribonucleosides; Treatment Outcome; Urokinase-Type Plasminogen Activator | 2011 |
GSTT1 gene abnormality in minimal change nephrotic syndrome with elevated serum immunoglobulin E.
Topics: Adolescent; Biomarkers; Biopsy; Child; Comparative Genomic Hybridization; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Glutathione Transferase; Humans; Immunoglobulin E; Immunosuppressive Agents; Male; Mutation; Nephrosis, Lipoid; Polymerase Chain Reaction; Proteinuria; Reactive Oxygen Species; Ribonucleosides; T-Lymphocytes, Helper-Inducer; Treatment Outcome | 2012 |
Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Pilot Projects; Prednisolone; Proteinuria; Remission Induction; Retrospective Studies; Ribonucleosides; Tacrolimus; Treatment Outcome | 2012 |
[Angiotensin type 1 receptor blocker reduced proteinuria in patients of focal glomerular sclerosis].
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Diet, Protein-Restricted; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Losartan; Male; Methylprednisolone; Middle Aged; Prednisolone; Proteinuria; Remission Induction; Ribonucleosides; Tetrazoles; Valine; Valsartan | 2004 |
Mizoribine decreases urinary protein excretion in two patients with IgA nephropathy.
Topics: Adult; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Middle Aged; Proteinuria; Ribonucleosides | 2005 |
Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
Topics: Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone; Proteinuria; Recurrence; Remission Induction; Ribonucleosides | 2006 |
Mizoribine corrects defective nephrin biogenesis by restoring intracellular energy balance.
Topics: Adenosine Triphosphate; Animals; Cells, Cultured; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Energy Metabolism; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Intracellular Membranes; Kidney Glomerulus; Male; Membrane Proteins; Membrane Transport Proteins; Mice; Nephrotic Syndrome; Podocytes; Protein Processing, Post-Translational; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Ribonucleosides; RNA, Messenger; Stress, Physiological | 2007 |
Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy.
Topics: Adolescent; Child; Drug Resistance; Female; Glomerulonephritis, IGA; Hematuria; Humans; Immunosuppressive Agents; Kidney; Macrophage Activation; Methylprednisolone; Prednisolone; Proteinuria; Ribonucleosides; Treatment Outcome | 2008 |
Modification of crescentic Masugi nephritis in the rabbit by Bredinin, a new immunosuppressant.
Topics: Animals; Antibody Formation; Creatinine; Glomerulonephritis; Kidney Glomerulus; Proteinuria; Rabbits; Ribonucleosides; Time Factors | 1983 |
Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children.
Topics: Child; Child, Preschool; Combined Modality Therapy; Humans; Immunosuppressive Agents; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Ribonucleosides | 1994 |
Early steroid withdrawal after kidney transplantation.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Azathioprine; CD4-CD8 Ratio; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Leukocyte Count; Lymphocyte Count; Lymphocyte Subsets; Male; Methylprednisolone; Proteinuria; Ribonucleosides; Treatment Outcome; Triglycerides | 1996 |
Effects of deoxyspergualine on chronic transplant nephropathy.
Topics: Azathioprine; Biomarkers; Chronic Disease; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Guanidines; Humans; Immunoglobulin G; Immunosuppressive Agents; Interleukin-6; Kidney Transplantation; Male; Proteinuria; Ribonucleosides; Steroids | 1996 |
Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside.
Topics: Animals; Antibiotics, Antineoplastic; Immunosuppressive Agents; Male; Nephrosis; Nephrosis, Lipoid; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Ribonucleosides; Thromboxane B2 | 1996 |
Effect of mizoribine on pulmonary lesions in MRL/lpr/lpr mice.
Topics: Animals; Antibody Formation; Autoantibodies; Autoimmune Diseases; Bronchoalveolar Lavage Fluid; Cricetinae; Female; Immunosuppressive Agents; Lung; Lung Diseases; Macrophage Activation; Macrophages, Alveolar; Mice; Mice, Inbred MRL lpr; Proteinuria; Ribonucleosides; Survival Rate | 1996 |
Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice.
Topics: Animals; B-Lymphocytes; Disease Models, Animal; Flow Cytometry; Glomerular Mesangium; Glomerulonephritis; Glomerulonephritis, IGA; Immunoglobulin A; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Proteinuria; Ribonucleosides | 1998 |
Mizoribine for childhood IgA nephropathy.
Topics: Adolescent; Child; Child, Preschool; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Male; Proteinuria; Ribonucleosides | 1999 |
Effect of mizoribine on serum IgE concentration in patients with IgA nephropathy.
Topics: Adult; Case-Control Studies; Female; Glomerulonephritis, IGA; Humans; Immunoglobulin E; Immunosuppressive Agents; Male; Proteinuria; Ribonucleosides; T-Lymphocytes | 2001 |